Gyre Therapeutics Statistics

Total Valuation

GYRE has a market cap or net worth of $574.73 million. The enterprise value is $525.74 million.

Market Cap	574.73M
Enterprise Value	525.74M

Important Dates

The next estimated earnings date is Monday, August 10, 2026, after market close.

Earnings Date	Aug 10, 2026
Ex-Dividend Date	n/a

Share Statistics

GYRE has 91.37 million shares outstanding. The number of shares has decreased by -11.33% in one year.

Current Share Class	91.37M
Shares Outstanding	91.37M
Shares Change (YoY)	-11.33%
Shares Change (QoQ)	+0.21%
Owned by Insiders (%)	6.66%
Owned by Institutions (%)	3.74%
Float	21.28M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.91
Forward PS	7.21
PB Ratio	5.67
P/TBV Ratio	5.94
P/FCF Ratio	187.03
P/OCF Ratio	133.07
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 103.64, with an EV/FCF ratio of 171.09.

EV / Earnings	n/a
EV / Sales	4.49
EV / EBITDA	103.64
EV / EBIT	217.61
EV / FCF	171.09

Financial Position

The company has a current ratio of 4.64, with a Debt / Equity ratio of 0.01.

Current Ratio	4.64
Quick Ratio	3.68
Debt / Equity	0.01
Debt / EBITDA	0.14
Debt / FCF	0.27
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -3.08% and return on invested capital (ROIC) is -17.79%.

Return on Equity (ROE)	-3.08%
Return on Assets (ROA)	1.03%
Return on Invested Capital (ROIC)	-17.79%
Return on Capital Employed (ROCE)	1.70%
Weighted Average Cost of Capital (WACC)	31.28%
Revenue Per Employee	$187,278
Profits Per Employee	-$10,179
Employee Count	625
Asset Turnover	0.80
Inventory Turnover	0.60

Taxes

In the past 12 months, GYRE has paid $4.28 million in taxes.

Income Tax	4.28M
Effective Tax Rate	758.16%

Stock Price Statistics

The stock price has decreased by -15.11% in the last 52 weeks. The beta is 4.92, so GYRE's price volatility has been higher than the market average.

Beta (5Y)	4.92
52-Week Price Change	-15.11%
50-Day Moving Average	6.71
200-Day Moving Average	7.45
Relative Strength Index (RSI)	50.70
Average Volume (20 Days)	127,039

Short Selling Information

The latest short interest is 1.67 million, so 1.83% of the outstanding shares have been sold short.

Short Interest	1.67M
Short Previous Month	1.68M
Short % of Shares Out	1.83%
Short % of Float	7.86%
Short Ratio (days to cover)	18.60

Income Statement

In the last 12 months, GYRE had revenue of $117.05 million and -$6.36 million in losses. Loss per share was -$0.08.

Revenue	117.05M
Gross Profit	111.30M
Operating Income	2.42M
Pretax Income	564,000
Net Income	-6.36M
EBITDA	5.07M
EBIT	2.42M
Loss Per Share	-$0.08

Full Income Statement

Balance Sheet

The company has $49.81 million in cash and $823,000 in debt, giving a net cash position of $48.99 million or $0.54 per share.

Cash & Cash Equivalents	49.81M
Total Debt	823,000
Net Cash	48.99M
Net Cash Per Share	$0.54
Equity (Book Value)	136.99M
Book Value Per Share	1.11
Working Capital	71.94M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $4.32 million and capital expenditures -$1.25 million, giving a free cash flow of $3.07 million.

Operating Cash Flow	4.32M
Capital Expenditures	-1.25M
Depreciation & Amortization	2.66M
Net Borrowing	n/a
Free Cash Flow	3.07M
FCF Per Share	$0.03

Full Cash Flow Statement

Margins

Gross margin is 95.09%, with operating and profit margins of 2.06% and -5.44%.

Gross Margin	95.09%
Operating Margin	2.06%
Pretax Margin	0.48%
Profit Margin	-5.44%
EBITDA Margin	4.33%
EBIT Margin	2.06%
FCF Margin	2.63%

Dividends & Yields

GYRE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	11.33%
Shareholder Yield	11.33%
Earnings Yield	-1.11%
FCF Yield	0.53%

Analyst Forecast

The average price target for GYRE is $18.67, which is 196.82% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$18.67
Price Target Difference	196.82%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (3Y)	54.92%
EPS Growth Forecast (3Y)	119.68%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

GYRE has an Altman Z-Score of 18 and a Piotroski F-Score of 5.

Altman Z-Score	18
Piotroski F-Score	5